Laser speckle imaging to monitor leg perfusion before, during and after revascularization
Official title: SPECTATOR: Perfusion Monitoring Before, During and After Lower Extremity Revascularization With Laser Speckle Contrast Imaging
Run by Leiden University Medical Center · NCT07558174 · Data updated 2026-11-12
This study tries a non-invasive laser speckle imaging method to see if it can measure blood flow in the legs of people having lower-extremity revascularization.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Leiden University Medical Center Academic / other |
| Locations | 1 site (Leiden, South Holland) |
| Status | Recruiting |
| Started | September 2026 |
| Main results expected | May 2028 |
| Study ends | June 2028 |
| Registry record updated | September 23, 2026 |
| Trial ID | NCT07558174 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults scheduled for lower-extremity revascularization at Leiden University Medical Center who will have pre- and postoperative ICG NIRF measurements and can give informed consent.
✕Probably not a fit
Patients who are not undergoing revascularization, cannot undergo ICG NIRF imaging as required by the protocol, or have medical conditions judged by investigators to jeopardize safety are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will use laser speckle contrast imaging (LSCI) to record real-time perfusion of the lower limb before, during, and after revascularization procedures. LSCI measurements will be performed perioperatively and compared with standard indocyanine green near-infrared fluorescence (ICG NIRF) and temperature readings to explore correlations. Participants are patients scheduled for lower-extremity revascularization at Leiden University Medical Center who undergo pre- and postoperative ICG NIRF imaging. The study aims to test feasibility and signal quality of LSCI as a quick, dye-free alternative for bedside perfusion monitoring.
Why it matters
Potential benefit: If successful, LSCI could offer a quick, non-invasive way to visualize limb perfusion during revascularization and help surgeons predict or improve outcomes without dye injection.
How similar studies have gone: ICG NIRF has shown promise for guiding revascularization, but LSCI is a newer, non-invasive modality with limited prior clinical validation in this setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Scheduled for lower-extremity revascularization * Undergoing pre- and postoperative indocyanine near-infrared fluorescence perfusion measurements Exclusion Criteria: Any condition that the investigator considers to be potentially jeopardizing the patient's wellbeing or the study objectives
Where it's running
-
Leiden University Medical Center
Leiden, South Holland, Netherlands Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing radiofrequency and microwave treatments for small varicose veins
This study is testing whether ultrasound-guided radiofrequency or microwave treatments work better for people with small varicose veins.
-
Observing pain during microwave treatment for varicose veins
This study looks at how much pain patients feel during microwave treatment for varicose veins to see if different factors like age and weight affect their experience, with the goal of making the procedure more comfortable.
-
How inflammation relates to heart health and walking ability in people with peripheral artery disease (PANACEA-O)
This project will see if blood inflammation levels are linked with heart health and walking ability in adults with symptomatic peripheral artery disease who get care in Canadian heart clinics.
-
Evero everolimus-coated balloon versus paclitaxel-coated balloon for femoropopliteal PAD
This study will test whether an Everolimus-coated balloon works as safely and effectively as paclitaxel-coated balloons to open blockages in leg arteries for people with PAD and walking pain.
-
Helping people walk better after leg revascularization for peripheral artery disease
This project will see if adding a home-based walking program or taking nitrate-rich beetroot juice after leg revascularization helps people with peripheral artery disease walk farther and faster.
-
Using light therapy to enhance walking in patients with peripheral artery disease
This study is testing if daily light therapy can help people with peripheral artery disease walk farther and improve their overall health when combined with home exercises.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.